RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Raw

AbbVie Inc.ABBV

Market cap
$417.4B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Net earnings-------4,62211,54911,8454,8734,286
Depreciation388383417425425471464666803778752764
Amortization of intangible assets5094034197641,1001,3001,6005,8007,7007,7007,9007,600
Deferred income taxes------122-2,325-898-1,931-2,889-1,449
Change in fair value of contingent consideration liabilities---228626493,0915,7532,6792,7615,1283,771
Payments of contingent consideration liabilities----------8701,995
Stock-based compensation212241282353365421430753692671747911
Acquired IPR&D and milestones-1,1022802804701,0614901,3761,6246977782,757
Gain on divestitures------330-68172--
Non-cash litigation reserve adjustments, net of cash payments---------2,243-443508
Impairment of intangible assets----3545,0701,030--7704,2294,476
Other, net-34-434-489-429-84-76-43-832-15022563
Accounts receivable---71391591749291,3211,455-66-207
Inventories5620343438-9322623140142686417319
Prepaid expenses and other assets-459220-511393118499-97-134197264188-361
Accounts payable and other liabilities-426-1931,503-1,187425190-1,1211,5141,6281,6053,840177
Income tax assets and liabilities, net--------573-1,290542-488-3,208
Cash flows from operating activities------13,32417,58822,77724,94322,83918,806
Acquisition of businesses, net of cash acquired40562211,4882,495---38,260525255-17,493
Other acquisitions and investments--9642623087361,1351,4001,4005391,2003,000
Acquisitions of property and equipment491612532479529638552798787695777974
Purchases of investment securities9301,1698515,3152,2301,792583611191,4387773
Sales and maturities of investment securities2,7051,4778802,3592,7932,1602,6991,525981,53055555
Other, net---19-118---167-1,387-366-774-13-189
Cash flows from investing activities------596-37,557-2,344-623-2,009-20,820
Proceeds from Short-Term Debt-----------5,008
Repayments of Other Short-Term Debt------3,000----5,008
Proceeds from issuance of long-term debt--20,66011,627-5,96331,4823,0001,0002,000-16,963
Repayments of long-term debt and finance lease obligations--4,0186,010256,0351,5365,6839,41414,4334,1499,613
Debt issuance costs--18269-4042420--3899
Dividends paid2,5552,6613,2943,7174,1075,5806,3667,7169,26110,04310,53911,025
Purchases of treasury stock3206527,5676,0331,41012,0146299789341,4871,9721,708
Proceeds from Stock Options Exercised347225142268254738209244262180214
Payments of contingent consideration liabilities----268781633216981,132752-
Other, net-66-2173035221435824304857
Cash flows from financing activities------14,39618,708-11,501-19,039-24,803-17,222-5,211
Effect of exchange rate changes on cash and equivalents----------625-65
Net change in cash and equivalents--------31,4751,297-5453,613-7,290
Interest paid, net of portion capitalized2834195369861,0991,2151,7942,6192,7122,5462,4692,811
Income taxes paid1,3054981,1083,5631,696-1,4471,6743,6482,9884,7024,064